glp 1 and cannabinoids GLP-1 boom nudges cannabis dispensaries to rethink offerings Upper Specialty | MNGI Peach Buy More Save More:Triple Pack

glp 1 and cannabinoids GLP-1 boom nudges cannabis dispensaries to rethink offerings Upper Specialty | MNGI Peach Buy More Save More:Triple Pack

Upper Specialty | MNGI

Answer : The major players in the GLP-1 analogues market include Novo Nordisk, Eli Lilly and Company, Sanofi, AstraZeneca, Boehringer Ingelheim, Pfizer, Amgen, Roche, Zealand Pharma, Structure Therapeutics, Viking Therapeutics, Hangzhou Sciwind Biosciences, Fudan University, Eccogene, Medtronic, Merck & Co., AbbVie, Bayer AG, Teva Pharmaceutical Industries Ltd., and Boehringer Ingelheim

Peach

Buy More Save More:Triple Pack

She adds that the shakes have 26 grams (g) of protein in just 170 calories with no added sugar